Cargando…
The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model
Patients with coronavirus disease 2019 (COVID-19) have been frequently reported to exhibit neurological manifestations and disruption of the blood-brain barrier (BBB). Among the risk factors for BBB breakdown, the loss of endothelial cells and pericytes has caused widespread concern. Recent studies...
Autores principales: | Ju, Jiahang, Su, Yuwen, Zhou, You, Wei, Hui, Xu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445123/ https://www.ncbi.nlm.nih.gov/pubmed/36082238 http://dx.doi.org/10.3389/fncel.2022.897564 |
Ejemplares similares
-
Mild Traumatic Brain Injury-Induced Disruption of the Blood-Brain Barrier Triggers an Atypical Neuronal Response
por: Munoz-Ballester, Carmen, et al.
Publicado: (2022) -
G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier
por: Pluimer, Brock R., et al.
Publicado: (2020) -
Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties
por: Ravid, Orly, et al.
Publicado: (2018) -
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
por: Peng, Xiaoyao, et al.
Publicado: (2021) -
Severe Blood–Brain Barrier Disruption in Cardioembolic Stroke
por: Liu, Chang, et al.
Publicado: (2018)